Glibenclamide reverses cardiovascular abnormalities of Cantú Syndrome driven by KATP channel overactivity

View Content

McClenaghan C, Huang Y, Yan Z, Harter TM, Halabi CM, Chalk R, Kovacs A, van Haaften G, Remedi MS, and Nichols CG